Diverse Cutaneous Adverse Eruptions Caused by Anti-Programmed Cell Death-1 (PD-1) and Anti-Programmed Cell Death Ligand-1 (PD-L1) Immunotherapies: Clinical Features and Management
Therapeutic Advances in Medical Oncology - United States
doi 10.1177/1758834017751634
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2018
Authors
Publisher
SAGE Publications